KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma

Despite curative-intent treatment, most patients with locally advanced esophageal cancer will experience disease recurrence or locoregional progression, highlighting the need for new therapies. Current guidelines recommend definitive chemoradiotherapy in patients ineligible for surgical resection, b...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Future Oncol
Päätekijät: Shah, Manish A, Bennouna, Jaafar, Doi, Toshihiko, Shen, Lin, Kato, Ken, Adenis, Antoine, Mamon, Harvey J, Moehler, Markus, Fu, Xiaolong, Cho, Byoung Chul, Bordia, Sonal, Bhagia, Pooja, Shih, Chie-Schin, Desai, Anjali, Enzinger, Peter
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Future Medicine Ltd 2021
Aiheet:
Clinical Trial Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7927908/
https://ncbi.nlm.nih.gov/pubmed/33533655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2020-0969
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia